Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Long-Term Outcome of Unrelated Cord Blood Transplantation in Patients with Idiopathic Refractory Severe Aplastic Anemia: A Nationwide Phase 2 Study

Blood (2024) 144 (Supplement 1): 596.

https://doi.org/10.1182/blood-2024-194780

Published: 2024

Journal Articles

Characteristics and Outcome Determinants in Children, Adolescents and Young Adults Who Failed Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 1433.

https://doi.org/10.1182/blood-2024-209895

Published: 2024

Journal Articles

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Blood (2023) 142 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2023-175045

Published: 2023

Journal Articles

Failure and out of Specification Manufacturing of Autologous CAR-T Cells Could be Associated with a High Concentration of Total Nucleated Cells, CD3 + Cells and Neutrophils in the Apheresis Product

Guillaume Cohet, Cedrik NGO-Chin, Nadia Douki, Marion Desniaux, Stellie Cornu, Justine Nasone, Audrey Cras, Lionel Faivre, Nathalie Parquet, Anne Brignier, Dehbia Menouche, Emmanuelle Lesprit, Nabih Azar, Ramdane Belhocine, Isabelle Madelaine, Romain de JORNA, Jerome Larghero, Miryam Mebarki

Blood (2023) 142 (Supplement 1): 3520.

https://doi.org/10.1182/blood-2023-174865

Published: 2023

Journal Articles

Lenalidomide Exposure at Time of CAR T-Cells Expansion Enhances Response of Refractory/Relapsed Aggressive Large B-Cell Lymphomas

Jean Lemoine, Florence Morin, Roberta Di Blasi, Laetitia Vercellino, Alexis Cuffel, Naoufal Benlachgar, Jerome Larghero, Isabelle Madelaine, Julien Calvani, Veronique Meignin, Sophie Caillat-Zucman, Sylvie Chevret, Catherine Thieblemont

Blood (2021) 138 (Supplement 1): 1433.

https://doi.org/10.1182/blood-2021-151109

Published: 2021

Journal Articles

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Blood (2019) 134 (Supplement_1): 3876.

https://doi.org/10.1182/blood-2019-131123

Published: 2019

Journal Articles

Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1

Blood (2019) 133 (12): 1358–1370.

https://doi.org/10.1182/blood-2018-09-875674

Published: 2019

Includes: Supplemental data

Journal Articles

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Blood (2018) 132 (Supplement 1): 896.

https://doi.org/10.1182/blood-2018-99-111356

Published: 2018

Journal Articles

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

Blood (2018) 132 (7): 750–754.

https://doi.org/10.1182/blood-2018-01-829630

Published: 2018

Includes: Supplemental data

Journal Articles

Activity of nonmuscle myosin II isoforms determines localization at the cleavage furrow of megakaryocytes

Anita Roy, Larissa Lordier, Stefania Mazzi, Yunhua Chang, Valérie Lapierre, Jérome Larghero, Najet Debili, Hana Raslova, William Vainchenker

Blood (2016) 128 (26): 3137–3145.

https://doi.org/10.1182/blood-2016-04-711630

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

JAK2V617F - Positive Endothelial Cells Display Pro-Thrombotic Characteristics

Anna Guadall, PhD, Elodie Lesteven, PharmD, PhD, Gil Letort, Sarah Awan Toor, Doriane Pognant, Megane Brusson, Emmanuelle Verger, PhD, Jerome Larghero, PharmD, PhD, Valerie Vanneaux, PharmD, PhD, Christine Chomienne, MD PhD, Wassim El Nemer, PhD, Bruno Cassinat, PharmD, PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2016) 128 (22): 4273.

https://doi.org/10.1182/blood.V128.22.4273.4273

Published: 2016

Journal Articles

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Blood (2016) 128 (22): 2671.

https://doi.org/10.1182/blood.V128.22.2671.2671

Published: 2016

Journal Articles

Impact of the JAK2V617F Mutation on the Hemato-Endothelial Differentiation in an Induced Pluripotent Stem Cells (iPSC) Model

Elodie Lesteven, PharmD, PhD, Doriane Pognant, Valerie Vanneaux, PharmD, PhD, Jérome Larghero, PharmD, PhD, Olivier Feraud, Annelise Bennaceur-Griscelli, MD PhD, Emmanuelle Verger, PhD, Annalisa Andreoli, MD, Christine Chomienne, MD PhD, Bruno Cassinat, PharmD, PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2014) 124 (21): 4570.

https://doi.org/10.1182/blood.V124.21.4570.4570

Published: 2014

Journal Articles

High Numbers Of Memory T Cells Are Associated With Higher Risk Of Grade II-IV Acute Gvhd After Human Allogeneic Transplantation

Michael Loschi, Régis Peffault de Latour, MD, Raphael Porcher, PhD, Valerie Vanneaux, Marie Robin, MD, PhD, Alienor Xhaard, MD, Jerome Larghero, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 2061.

https://doi.org/10.1182/blood.V122.21.2061.2061

Published: 2013

Journal Articles

Multiparameter single-cell profiling of human CD4 + FOXP3 + regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

Shen Dong, Sylvie Maiella, Aliénor Xhaard, Yuanyu Pang, Lynn Wenandy, Jérome Larghero, Christophe Becavin, Arndt Benecke, Elisabetta Bianchi, Gérard Socié, Lars Rogge

Blood (2013) 122 (10): 1802–1812.

https://doi.org/10.1182/blood-2013-02-482539

Published: 2013

Includes: Supplemental data

Journal Articles

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Sophie Servais, Raphaël Porcher, Marie Robin, Alienor Xhaard, Emeline Masson, Jerome Larghero, Patricia Ribaud, Sarah Abbes, Nathalie Dhedin, Gerard Socie, Regis Peffault de Latour

Blood (2012) 120 (21): 2000.

https://doi.org/10.1182/blood.V120.21.2000.2000

Published: 2012

Journal Articles

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Marie Sebert, Raphaël Porcher, Marie Robin, Lionel Ades, MD, PhD, Emmanuel Raffoux, Alienor Xhaard, Nathalie Dhedin, MD, Jerome Larghero, Chantal Himberlin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, MD, PhD, Gérard Socié, MD PhD, Regis Peffault de Latour

Blood (2012) 120 (21): 3103.

https://doi.org/10.1182/blood.V120.21.3103.3103

Published: 2012

Journal Articles

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation

Régis Peffault de Latour, Rodrigo T. Calado, Marc Busson, Jeffrey Abrams, Nadir Adoui, Marie Robin, Jérôme Larghero, Nathalie Dhedin, Alienor Xhaard, Emmanuel Clave, Dominique Charron, Antoine Toubert, Pascale Loiseau, Gérard Socié, Neal S. Young

Blood (2012) 120 (16): 3353–3359.

https://doi.org/10.1182/blood-2012-01-403337

Published: 2012

Includes: Supplemental data

Journal Articles

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

Blood (2011) 118 (9): 2551–2555.

https://doi.org/10.1182/blood-2010-12-324707

Published: 2011

Includes: Supplemental data

Journal Articles

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

Blood (2011) 117 (15): e161–e170.

https://doi.org/10.1182/blood-2010-09-308726

Published: 2011

Includes: Supplemental data

NARROW

Long-Term Outcome of Unrelated Cord Blood Transplantation in Patients with Idiopathic Refractory Severe Aplastic Anemia: A Nationwide Phase 2 Study

Characteristics and Outcome Determinants in Children, Adolescents and Young Adults Who Failed Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Failure and out of Specification Manufacturing of Autologous CAR-T Cells Could be Associated with a High Concentration of Total Nucleated Cells, CD3 + Cells and Neutrophils in the Apheresis Product

Lenalidomide Exposure at Time of CAR T-Cells Expansion Enhances Response of Refractory/Relapsed Aggressive Large B-Cell Lymphomas

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

Activity of nonmuscle myosin II isoforms determines localization at the cleavage furrow of megakaryocytes

JAK2V617F - Positive Endothelial Cells Display Pro-Thrombotic Characteristics

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Impact of the JAK2V617F Mutation on the Hemato-Endothelial Differentiation in an Induced Pluripotent Stem Cells (iPSC) Model

High Numbers Of Memory T Cells Are Associated With Higher Risk Of Grade II-IV Acute Gvhd After Human Allogeneic Transplantation

Multiparameter single-cell profiling of human CD4 + FOXP3 + regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only